Open AccessPara‐aortic lymph node metastasis in malignant dysgerminoma of the ovary
Author(s) -
KASENDA BENJAMIN,
HARTER PHILIPP,
HIRSCH TOBIAS,
AST ALEXANDER,
BUHRMANN CHRISTINE,
GLASER FLORIAN,
DU BOIS ANDREAS
Publication year - 2009
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.3109/00016340903242461
Subject(s) - medicine , dysgerminoma , lymphadenectomy , etoposide , chemotherapy , metastasis , oncology , stage (stratigraphy) , lymph node , surgery , ovary , cancer , paleontology , biology
Dysgerminomas comprise approximately 2–5% of all ovarian malignancies and mostly affect young adolescent women. Primary comprehensive surgery and adjuvant chemotherapy consisting of bleomycin, etoposide, and cisplatin (BEP) are the current recommended treatment options, the latter reserved for advanced stages (FIGO II–IV). We report two patients aged 20 and 26 years who presented with an initial FIGO stage IA, but inadequately assessed. Both were subsequently diagnosed with recurrent malignant dysgerminoma and para‐aortic lymph node metastasis. Neither had received comprehensive staging at initial surgery nor adjuvant radio or chemotherapy. Both needed extensive surgery and multiagent chemotherapy for survival and belong to the small percentage of FIGO IA dysgerminoma patients showing a relapse. Comprehensive initial surgery including systematic para‐aortic lymphadenectomy and adjuvant chemotherapy at tertiary referral centers is needed to minimize the treatment burden.